DELiver Therapeutics
Houston, US · 1 known investors
Find your way into DELiver Therapeutics
116 people in our graph share verified history with the DELiver Therapeutics team — schools, employers, funds. One of them is your warm intro.
Scott Billerunlockedknows Kevin M. Slawin · together at Columbia University (overlapped)
knows the team · via Bellicum Pharmaceuticals, Inc.
×2knows the team · via Columbia University
×5knows the team · via Baylor College of Medicine
×2knows the team · via Columbia University Vagelos College of Physicians and Surgeons
knows the team · via Memorial Hermann Healthcare System
DELiver Therapeutics develops small molecule and peptide therapeutics using high-throughput DNA encoded library (DEL) drug screening to address challenging and previously "undruggable" targets in clinical medicine, with a focus on tyrosine kinase targets. Its R&D facilities are located at K2Bio in Houston.
Founders & leadership
KS
Kevin Slawinin𝕏FounderKevin Slawin is a prostate cancer surgeon and biotech entrepreneur who co-invented the Prostate Health Index diagnostic test and cell therapy technologies including GoCAR-T. He founded or co-founded multiple biotech companies including Bellicum Pharmaceuticals, which completed an IPO in 2014, and currently leads DELiver Therapeutics, Eos SENOLYTIX, Phoenix SENOLYTIX, and PrintBio.
Investors · 1
Frequently asked questions
- What does DELiver Therapeutics do?
- DELiver Therapeutics develops small molecule and peptide therapeutics using high-throughput DNA encoded library (DEL) drug screening to address challenging and previously "undruggable" targets in clinical medicine, with a focus on tyrosine kinase targets. Its R&D facilities are located at K2Bio in Houston.
- Who founded DELiver Therapeutics?
- DELiver Therapeutics was founded by Kevin Slawin.
- Who are DELiver Therapeutics's investors?
- DELiver Therapeutics's investors include Rapha Capital Management, LLC.
- Where is DELiver Therapeutics headquartered?
- DELiver Therapeutics is headquartered in Houston, US.